The anti-inflammatory properties of the phosphodiesterase (PDE)-5 inhibitor, sildenafil, make it a potential therapy for asthma and COPD

Author:  

Publisher: Adis International

ISSN: 1173-8324

Source: Inpharma, Vol.1, Iss.1425, 2004-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content